Clinical LLM Performance Improves by >300% When Provided With High-Quality Real-World Evidence in New Precision Medicine Benchmark

Read the release
Logo
  • Solutions
        • Health Systems
          • Pharmacy
          • Research Informatics
          • Value Based Care / Quality
          • GME
        • Life Sciences
          • Precision Medicine AI/ML
          • HEOR, Medical Affairs & RWE
          • Research & Development
          • Commercial Analytics
  • Technology
        • Content
          • Alexandria®
        • Automation Solutions
          • Atropos Evidence™ Agent
          • ChatRWD®
          • Green Button®
          • Forge®
        • Data
          • GENEVA OS®
          • Atropos Evidence™ Network
          • Data Quality Scoring
  • About
    • About Us
    • Careers
  • Resources
    • Resource Center
    • Publications
    • Customer Stories
    • News & Media
    • Press Releases
    • Blog
  • Contact Us
  • Login
Syntegra & Atropos Partner to Generate Evidence from Synthetic Data

Syntegra & Atropos Partner to Generate Evidence from Synthetic Data

by a9b1da23_admin | Nov 1, 2022 | Press Release

Today Syntegra and Atropos Health have announced a partnership that will enable users of Atropos Health’s Green Button Informatics Consult and Evidence Platform to leverage Syntegra’s market-leading, privacy-preserving synthetic data – in addition to...
Bessemer Venture Partners: Direct-to-clinician—How product-led growth is changing healthcare and life sciences

Bessemer Venture Partners: Direct-to-clinician—How product-led growth is changing healthcare and life sciences

by a9b1da23_admin | Sep 28, 2022 | News and Media

September 28, 2022 — Atropos Health is featured in a piece on “the new DTC – Direct to Clinician” by Morgan Cheatham at Bessemer Venture Partners. It’s a compelling assessment – check out the full text here & key highlights below. “As our current...
Recent Publication on the Gut Microbiome’s Role in Gout Features Atropos Health’s RWE

Recent Publication on the Gut Microbiome’s Role in Gout Features Atropos Health’s RWE

by a9b1da23_admin | Sep 23, 2022 | News and Media

The choice of antibiotic may affect your gut microbiota which in turn influences uric acid metabolism and risk of gout. Atropos Health’s RWE capabilities supported the novel discovery of a widely distributed gene cluster integral to uric acid metabolism, and how uric...
Precision Medicine in Radiation Oncology: Atropos Health’s Keynote Speech at Ci4CC

Precision Medicine in Radiation Oncology: Atropos Health’s Keynote Speech at Ci4CC

by a9b1da23_admin | Aug 31, 2022 | Conference, News and Media, Presentations

At this year’s Ci4CC conference from 8/29-8/31 in Santa Barbara, CA, physicians and researchers from across the United States and abroad convened to discuss the importance of precision medicine in Radiation Oncology. The topic hits close to home for Atropos Health’s...
MedCity News: Stanford spinout raises $14M for its point-of-care physician consult service

MedCity News: Stanford spinout raises $14M for its point-of-care physician consult service

by a9b1da23_admin | Aug 10, 2022 | News and Media

Read Katie Adams’s coverage of our fundraising and CEO announcements in MedCity News here: There’s a severe evidence gap in healthcare treatment guidelines. Clinical trials shape most care guidelines and payer decisions, yet they exclude about 70% of the U.S....
« Older Entries
Next Entries »
DiviWP Logo
  • Follow
  • Follow

Solutions

Health Systems

Pharmacy

Research Informatics

Value Based Care / Quality

GME

Life Sciences

Precision Medicine AI/ML

HEOR, Medical Affairs & RWE

Research & Development

Commercial Analytics

Technology

Content

Alexandria®

Automation Solutions

Atropos Evidence™ Agent

ChatRWD®

Green Button®

Forge®

Data

GENEVA OS®

Atropos Evidence™ Network

Data Quality Scoring

About

  • About Us
  • Careers

Resources

  • Resources Center
  • Publications
  • Customer Stories
  • News & Media
  • Press Releases
  • Blog

Copyright © 2026 Atropos Health. All Rights Reserved | Privacy Policy | Ethics Report | Terms of Service

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}